Marilyne Labrie

2.4k total citations · 2 hit papers
38 papers, 1.4k citations indexed

About

Marilyne Labrie is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Marilyne Labrie has authored 38 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 16 papers in Oncology and 15 papers in Immunology. Recurrent topics in Marilyne Labrie's work include Galectins and Cancer Biology (11 papers), PARP inhibition in cancer therapy (9 papers) and Glycosylation and Glycoproteins Research (5 papers). Marilyne Labrie is often cited by papers focused on Galectins and Cancer Biology (11 papers), PARP inhibition in cancer therapy (9 papers) and Glycosylation and Glycoproteins Research (5 papers). Marilyne Labrie collaborates with scholars based in Canada, United States and China. Marilyne Labrie's co-authors include Gordon B. Mills, Yves St‐Pierre, Joan S. Brugge, Ioannis K. Zervantonakis, Zhenlin Ju, Wei Zhao, Jianfeng Shen, Timothy A. Yap, Yang Peng and Guang Peng and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and Nature reviews. Cancer.

In The Last Decade

Marilyne Labrie

36 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

PARPi Triggers the STING-Dependent Immune Response and Enhances the Therapeutic Efficacy of Immune Checkpoint Blockade Independent of BRCAness

2018 427 citations Jianfeng Shen, Wei Zhao et al. Cancer Research profile →
Therapy resistance: opportunities created by adaptive responses to targeted therapies in cancer

2022 212 citations Marilyne Labrie, Gordon B. Mills et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Marilyne Labrie Canada	17	786	550	529	198	130	38	1.4k
Anita K. Mehta United States	12	442 0.6×	457 0.8×	345 0.7×	162 0.8×	118 0.9×	20	970
Eva Schut Netherlands	13	879 1.1×	707 1.3×	201 0.4×	228 1.2×	96 0.7×	15	1.3k
Julia V. Burnier Canada	21	592 0.8×	408 0.7×	174 0.3×	318 1.6×	123 0.9×	73	1.2k
Wendy Béguelin United States	20	763 1.0×	555 1.0×	402 0.8×	191 1.0×	83 0.6×	34	1.4k
Tsuyoshi Takahashi Japan	16	426 0.5×	421 0.8×	340 0.6×	124 0.6×	142 1.1×	34	1.1k
Patsy G. Oliver United States	22	1.1k 1.4×	509 0.9×	290 0.5×	308 1.6×	101 0.8×	35	1.5k
Julia Boshuizen Netherlands	8	582 0.7×	625 1.1×	225 0.4×	112 0.6×	95 0.7×	11	952
Sara Ricardo Portugal	22	879 1.1×	874 1.6×	219 0.4×	487 2.5×	201 1.5×	54	1.7k
Sebastian Oeck Germany	17	907 1.2×	379 0.7×	129 0.2×	322 1.6×	248 1.9×	30	1.3k
Fátima Valdés‐Mora Australia	19	975 1.2×	415 0.8×	334 0.6×	277 1.4×	128 1.0×	31	1.5k

Countries citing papers authored by Marilyne Labrie

Since Specialization

Citations

This map shows the geographic impact of Marilyne Labrie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marilyne Labrie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marilyne Labrie more than expected).

Fields of papers citing papers by Marilyne Labrie

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marilyne Labrie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marilyne Labrie. The network helps show where Marilyne Labrie may publish in the future.

Co-authorship network of co-authors of Marilyne Labrie

This figure shows the co-authorship network connecting the top 25 collaborators of Marilyne Labrie. A scholar is included among the top collaborators of Marilyne Labrie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marilyne Labrie. Marilyne Labrie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lai, Hui‐Ling, Guannan Li, Qin Yu, et al.. (2025). Rictor orchestrates β-catenin/FOXO balance by maintaining redox homeostasis during development of ovarian cancer. Oncogene. 44(23). 1820–1832.

Mills, Gordon B. & Marilyne Labrie. (2024). Enhancing anticancer activity of macrophages through rational drug combinations. Journal of Clinical Investigation. 134(9). 3 indexed citations

Labrie, Marilyne, et al.. (2024). T peripheral helper (Tph) cells, a marker of immune activation in cancer and autoimmune disorders. Clinical Immunology. 266. 110325–110325. 1 indexed citations

Labrie, Marilyne, et al.. (2024). Current preclinical models of brain metastasis. Clinical & Experimental Metastasis. 42(1). 5–5. 1 indexed citations

Lei, Jonathan T., Eric J. Jaehnig, Hannah Smith, et al.. (2023). The Breast Cancer Proteome and Precision Oncology. Cold Spring Harbor Perspectives in Medicine. 13(10). a041323–a041323. 2 indexed citations

Liu, Xuan, Zhongqi Ge, Fei Yang, et al.. (2022). Identification of biomarkers of response to preoperative talazoparib monotherapy in treatment naïve gBRCA+ breast cancers. npj Breast Cancer. 8(1). 64–64. 5 indexed citations

Ternes, Luke, Mark Dane, Sean M. Gross, et al.. (2022). A multi-encoder variational autoencoder controls multiple transformational features in single-cell image analysis. Communications Biology. 5(1). 255–255. 26 indexed citations

Pejović, Tanja, et al.. (2022). Single-Cell Proteomics Analysis of Recurrent Low-Grade Serous Ovarian Carcinoma and Associated Brain Metastases. Frontiers in Oncology. 12. 903806–903806. 3 indexed citations

Li, Allen, Jamie M. Keck, Swapnil Parmar, et al.. (2021). Characterizing advanced breast cancer heterogeneity and treatment resistance through serial biopsies and comprehensive analytics. npj Precision Oncology. 5(1). 28–28. 23 indexed citations

10.

Labrie, Marilyne, Yong Fang, Nicholas D. Kendsersky, et al.. (2019). Using Reverse Phase Protein Array (RPPA) to Identify and Target Adaptive Resistance. Advances in experimental medicine and biology. 1188. 251–266. 8 indexed citations

11.

Shen, Jianfeng, Wei Zhao, Zhenlin Ju, et al.. (2018). PARPi Triggers the STING-Dependent Immune Response and Enhances the Therapeutic Efficacy of Immune Checkpoint Blockade Independent of BRCAness. Cancer Research. 79(2). 311–319. 427 indexed citations breakdown →

12.

Lai, Hui‐Ling, Qin Yu, Yi Ding, et al.. (2018). FAK-ERK activation in cell/matrix adhesion induced by the loss of apolipoprotein E stimulates the malignant progression of ovarian cancer. Journal of Experimental & Clinical Cancer Research. 37(1). 32–32. 25 indexed citations

13.

Peng, Xinxin, Xiaoyan Xu, Yumeng Wang, et al.. (2018). A-to-I RNA Editing Contributes to Proteomic Diversity in Cancer. Cancer Cell. 33(5). 817–828.e7. 160 indexed citations

14.

Labrie, Marilyne, et al.. (2017). Tissue and plasma levels of galectins in patients with high grade serous ovarian carcinoma as new predictive biomarkers. Scientific Reports. 7(1). 13244–13244. 38 indexed citations

15.

Labrie, Marilyne, et al.. (2015). Apolipoprotein D Transgenic Mice Develop Hepatic Steatosis through Activation of PPARγ and Fatty Acid Uptake. PLoS ONE. 10(6). e0130230–e0130230. 19 indexed citations

16.

Labrie, Marilyne, Maria Vladoiu, Andrée‐Anne Grosset, et al.. (2015). A Mutation in the Carbohydrate Recognition Domain Drives a Phenotypic Switch in the Role of Galectin-7 in Prostate Cancer. PLoS ONE. 10(7). e0131307–e0131307. 22 indexed citations

17.

Labrie, Marilyne, et al.. (2014). Cytosolic galectin-7 impairs p53 functions and induces chemoresistance in breast cancer cells. BMC Cancer. 14(1). 801–801. 28 indexed citations

18.

Campion, Carole G., et al.. (2014). The CCAAT/Enhancer-Binding Protein Beta-2 Isoform (CEBPβ-2) Upregulates Galectin-7 Expression in Human Breast Cancer Cells. PLoS ONE. 9(5). e95087–e95087. 14 indexed citations

19.

Labrie, Marilyne, et al.. (2013). Binding and Repressive Activities of Apolipoprotein E3 and E4 Isoforms on the Human ApoD Promoter. Molecular Neurobiology. 48(3). 669–680. 15 indexed citations

20.

Campion, Carole G., Marilyne Labrie, Geneviève Lavoie, & Yves St‐Pierre. (2013). Expression of Galectin-7 Is Induced in Breast Cancer Cells by Mutant p53. PLoS ONE. 8(8). e72468–e72468. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact